Diagnamed Holdings Corp.
DMED
CNSX
| Weiss Ratings | DMED - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | DMED - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | DMED - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.08 | |||
| Price History | DMED - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 20.00% | |||
| 60-Day Total Return | 20.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | -14.29% | |||
| 1-Year Total Return | -50.00% | |||
| 2-Year Total Return | -40.00% | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -53.85% | |||
| 52-Week Low % Change | 500.00% | |||
| Price | DMED - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.07 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Sep 17, 2024 | |||
| 52-Week High Price (Date) | Mar 18, 2024 | |||
| Valuation | DMED - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.69M | |||
| Enterprise Value | 1.62M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -25.30% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -12.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.03 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -3.52 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | DMED - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 80.76M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | DMED - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 416 800 2684 | |||
| Address | 82 Richmond Street East Toronto, ON M5C 1P1 | |||
| Website | www.diagnamed.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | DMED - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | DMED - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -108.16% | |||
| Return on Equity | -- | |||
| Income Statement | DMED - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -459.20K | |||
| Net Income (TTM) | -492.80K | |||
| Net Income Avl. to Common (TTM) | -492.80K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -426.62% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | -400.00% | |||
| Balance Sheet | DMED - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 79.50K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 113.90K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -203.40K | |||
| Current Ratio (Q) | 0.359 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 113.90K | |||
| Total Current Liabilities (Q) | 317.30K | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 317.30K | |||
| Total Common Equity (Q) | -203.40K | |||
| Cash Flow | DMED - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -256.60K | |||
| Levered Free Cash Flow (TTM) | -99.20K | |||
| Cash from Operations (TTM) | -256.60K | |||
